Kintara Therapeutics, Inc. has completed its merger with TuHURA Biosciences, Inc., changing its name to TuHURA and implementing a 1-for-35 reverse stock split, resulting in approximately 42 million shares outstanding, with TuHURA stockholders owning about 97.15% of the combined company.